Complete echo reports, zero clicks

FDA-cleared, AI-structured reports processed in under 2 minutes, accuracy levels interchangeable with expert human sonographers, editable annotations of Doppler and 2D views from any vendor – it’s all here.

Welcome to your future – on-premises, in the cloud or on mobile.

Get Started

Watch Video

Publications

Lancet

Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study

Euroecho

Validation of a Deep Learning-Based Automated Workflow for Interpretation of an Echocardiogram

The Lancet Women and Cardiovascular Disease Commission

Cardiovascular disease is the leading cause of death in women. Reducing the global burden by 2030

Heart disease has no boundaries – nor should you

Image acquisition guidance, auto-labelling of cardiac chambers and a powerful hardware partnership offer a complete mobile solution with AI-automated reporting for 2D, CW, PW and Tissue Doppler.

Learn More
Us2ai Health
About Us 2 Ai

About us

Now everyone can ultrasound! Us2 automates the fight against heart disease through AI. Our mission is to create affordable, easy-to-use tools that enable everyone full access to their heart health.

Learn More

Our partners

Sequoia
Edbi
Asingapore
Startup Health
Echonous
Ihh Healthcare
Healpartners
Aztra
Pappas
Roche

Videos

Us2ai

Watch Video

Fedex - Us2.ai

Us2ai

Watch Video

Us2.ai

Vs2

Watch Video

Startup Health Festival

Vs3

Watch Video

Awareness

Image for before footer

Watch Video

Us2.ai Sample Report

Better heart, better life

Us2.ai is building a future where everyone, from the most advanced tech-driven regions to the most resource-constrained communities, can have equal access to high quality, consistent and inexpensive echo analysis.

News

Ceeuflag
Jun 9, 2022

Us2.ai receives CE Mark and patent allowance for clinical workflow

Underuse Of Gdmt For Heart Failure Even Worse In Low Income Countries
Apr 21, 2022

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

Apr 19, 2022

The Imaging Wire interview